Metformin and aspirin treatment could lead to an improved survival rate for Type 2 diabetic patients with stage II and III colorectal adenocarcinoma relative to non-diabetic patients.
暂无分享,去创建一个
S. Bonin | G. Stanta | L. Cattin | A. De Monte | D. Brunetti | M. Malagoli | Francesca Lavanda | Erica Naibo